Stem cell regulatory networks, dynamics and ways to engineer them (Day 1, TMM2016)

Author: Hamideh Emrani, 10/25/16

This year’s Till & McCulloch Meetings (TMM2016) began with a diverse set of topics organized into three different plenary sessions. The first session, on regulatory networks in stem cells, began with Sara-Jane Dunn from Microsoft Research who introduced us to “The Reasoning Engine for Interaction Networks, RE:IN,” a computational tool that can synthesize and analyze…Read more

Challenging assumptions to expand our thinking? Insights from Session 1 of TMM2016

Author: Camila Londono, 10/25/16

The fifth Till & McCulloch Meetings started off with a bang, with an incredibly exciting and provocative talk by Dr. Sara-Jane Dunn that highlighted the predictive power of Boolean network models. Dr. Dunn, who works at Microsoft Research, introduced the idea of biological computation: a cell’s gene expression “decision making” can be modelled using Boolean…Read more

Right Turn: Finding a treatment for vision loss is looking up

Author: Stacey Johnson, 10/21/16

October 13, 2016 was World Sight Day and the month of October is dedicated to blindness and vision loss awareness. No doubt that is why the California Institute for Regenerative Medicine (CIRM) recently shared the third installment in its Stem Cells in Your Face series. In the video below, narrator Kevin McCormack, whose day job…Read more

Sculpted to a T: Synthetic T-cells for a more controlled immune response

Author: Holly Wobma, 10/18/16

I have a confession.  This is not a blog about stem cells. It is, however, a blog about cells with infinite possibilities of fate. Because we are entering the world of synthetic biology, where crafty cellular engineering has enabled a new level of control over immune cell function. This work comes out of Wendell Lim’s…Read more

STEMinism: Chasing diversity and equality in STEM

Author: Camila Londono, 10/14/16

On October 11 I attended SHE DID THAT, the Ada Lovelace event, held at the University of Toronto, that Samantha Payne wrote about in Signals earlier this week. It was an exciting evening that not only celebrated incredible women in science, but also served as a reminder that we have a long way to go…Read more

Ada Lovelace Day: celebrating women in STEM

Author: Samantha Payne, 10/11/16

Can you name five historically influential women in the STEM fields (science, technology, engineering and medicine)? What about three? I recently asked myself this question and found that I struggled to come up with names, despite the formal training I’ve received in science at both the undergraduate and graduate level. Yet there are many: from…Read more

Right Turn: Finding donors for multi-ethnic patients with rare blood diseases

Author: Guest, 10/07/16

Laine Jaremey is the Communications Specialist at CCRM. Laine has over eight years of experience as a strategic communicator with a focus in the health industry. She completed her Bachelor’s Degree in Communication Studies at Wilfrid Laurier University, and a Postgraduate certificate in Public Relations from Humber College. Follow her on Twitter @LaineJaremey Being diagnosed with…Read more

Would you buy a designer bag made from lab-grown human skin?

Author: Jovana Drinjakovic, 10/06/16

In case you haven’t heard, Tina Gorjanc, a UK-based fashion designer, shocked the fashion world this summer when she announced her Pure Human collection of luxury leather items, to be made from lab-grown human skin, engineered with the late designer Alexander McQueen’s DNA. I know, it makes your brain twist in on itself! As you…Read more

Right Turn: “Comic” twist on CRISPR

Author: Lisa Willemse, 09/30/16

There’s nothing really funny about the patent debate on CRISPR-Cas9 gene editing. It’s been a contentious and expensive court battle, that has thankfully steered clear of mud-slinging (mostly). Which is good, since there’s more than enough of that in the U.S. these days, thanks to the Donald. For those who have followed the CRISPR patent…Read more

Taking appropriate steps towards gene editing in Canada

Author: Guest, 09/29/16

Patrick Bedford is the new Manager of Clinical Translation and Regulatory Affairs at CCRM.  He holds a Master’s Degree in Bioethics and Health Law, and has over 10 years of experience applying federal regulations to emerging biotechnologies in Canada.   Back in August, I had the pleasure of attending a gene editing/CRISPR workshop, hosted by…Read more